Mercury
CAS 7439-97-6
Mercury (CAS 7439-97-6) is a pharmaceutical compound with 0 bioactivity targets and 1 adverse event association.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Mercury is linked to DTXSID1024172 in DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Mercury used for in pharmaceutical contexts?
Mercury (CAS 7439-97-6) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Mercury?
Mercury has 1 DrugCentral/FAERS adverse event association. Rendered reaction terms include Intentional overdose. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Mercury also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Mercury Compounds with EU status "restricted".
What clinical phase is Mercury in?
No phase 1-4 clinical development badge is rendered for Mercury because the matched compound identifier rows do not contain a max-phase value.